Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Vera Bril, MD

Professor of Neurology
Director, Ellen & Martin Prosserman Centre for Neuromuscular Diseases
University of Toronto
Toronto, Ontario, Canada

Disclosures

Disclosure: Vera Bril, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Akcea; Alexion; Alnylam; argenx; CSL Behring; Grifols; Immunovant; Ionis; Janssen; Momenta (now Johnson & Johnson); Octapharma; Powell-Mansfield; Sanofi; Takeda; UCB
Received grants for clinical research from: Akcea; argenx; CSL Behring; Grifols; Immunovant; Ionis; Momenta (now Johnson & Johnson); Octapharma; Takeda; UCB
Other: Patent Beneficiary: CSL Behring; Powell Mansfield

Editor

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / ABIM MOC

Comprehensive Care in Myasthenia Gravis: A Virtual Live Ask-the-Expert Series

Authors: Vera Bril, MD
CME / ABIM MOC Released: 4/19/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 4/19/2023

Start Activity

Target Audience and Goal Statement

This activity is intended for neurologists, ophthalmologists, and primary care physicians.

The goal of this activity is that learners will be more aware of current and emerging treatment options for myasthenia gravis (MG) and better able to integrate into clinical practice for improved patient outcomes.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Nature of disease burden experienced by patients with generalized MG
- Clinical trial outcomes for investigational therapies being studied for generalized MG
Have greater competence related to
- The selection of pharmacotherapy for MG based on the nature of symptoms experienced by patients

Disclosures

Faculty

Vera Bril, MD

Professor of Neurology
Director, Ellen & Martin Prosserman Centre for Neuromuscular Diseases
University of Toronto
Toronto, Ontario, Canada

Disclosures

Disclosure: Vera Bril, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Akcea; Alexion; Alnylam; argenx; CSL Behring; Grifols; Immunovant; Ionis; Janssen; Momenta (now Johnson & Johnson); Octapharma; Powell-Mansfield; Sanofi; Takeda; UCB
Received grants for clinical research from: Akcea; argenx; CSL Behring; Grifols; Immunovant; Ionis; Momenta (now Johnson & Johnson); Octapharma; Takeda; UCB
Other: Patent Beneficiary: CSL Behring; Powell Mansfield

Editor

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Neurology & Neurosurgery

CME / ABIM MOC

Comprehensive Care in Myasthenia Gravis: A Virtual Live Ask-the-Expert Series

Authors: Vera Bril, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 4/19/2022

Valid for credit through: 4/19/2023

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

CME / ABIM MOC Information

PDF Downloads

Patient Handout

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Vera Bril, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME / ABIM MOC

Comprehensive Care in Myasthenia Gravis: A Virtual Live Ask-the-Expert Series

Target Audience and Goal Statement

Disclosures

Faculty

Vera Bril, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Comprehensive Care in Myasthenia Gravis: A Virtual Live Ask-the-Expert Series

PDF Downloads